药品注册申请号:015197
申请类型:NDA (新药申请)
申请人:HIKMA
申请人全名:HIKMA PHARMACEUTICALS USA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 AMICAR AMINOCAPROIC ACID TABLET;ORAL 500MG Yes No AB 1964/06/03 Approved Prior to Jan 1, 1982 Discontinued
002 AMICAR AMINOCAPROIC ACID TABLET;ORAL 1GM Yes No AB 2004/06/24 Discontinued
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2008/08/19 SUPPL-43(补充) Approval Labeling STANDARD
2004/08/24 SUPPL-40(补充) Approval Labeling STANDARD
2004/06/24 SUPPL-39(补充) Approval Manufacturing (CMC) PRIORITY
2004/06/24 SUPPL-38(补充) Approval Manufacturing (CMC) PRIORITY
2004/06/24 SUPPL-37(补充) Approval Manufacturing (CMC) PRIORITY
2004/06/24 SUPPL-36(补充) Approval Manufacturing (CMC) PRIORITY
2000/11/27 SUPPL-35(补充) Approval Manufacturing (CMC) PRIORITY
2000/10/02 SUPPL-33(补充) Approval Manufacturing (CMC) PRIORITY
2000/04/03 SUPPL-34(补充) Approval Labeling STANDARD
1999/10/01 SUPPL-32(补充) Approval Manufacturing (CMC) PRIORITY
1997/04/16 SUPPL-30(补充) Approval Labeling STANDARD
1992/08/13 SUPPL-28(补充) Approval Manufacturing (CMC) PRIORITY
1992/02/11 SUPPL-29(补充) Approval Manufacturing (CMC) PRIORITY
1990/04/03 SUPPL-23(补充) Approval Labeling
1986/01/17 SUPPL-27(补充) Approval Labeling
1983/06/06 SUPPL-26(补充) Approval Labeling
1982/12/10 SUPPL-25(补充) Approval Labeling
1982/10/22 SUPPL-22(补充) Approval Manufacturing (CMC) PRIORITY
1982/09/22 SUPPL-24(补充) Approval Manufacturing (CMC) PRIORITY
1981/06/30 SUPPL-19(补充) Approval Manufacturing (CMC) PRIORITY
1977/02/09 SUPPL-15(补充) Approval Manufacturing (CMC) PRIORITY
1964/06/03 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity PRIORITY
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:AMINOCAPROIC ACID 剂型/给药途径:TABLET;ORAL 规格:500MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
015197 001 NDA AMICAR AMINOCAPROIC ACID TABLET;ORAL 500MG Discontinued Yes No AB Approved Prior to Jan 1, 1982 HIKMA
209060 001 ANDA AMINOCAPROIC ACID AMINOCAPROIC ACID TABLET;ORAL 500MG Prescription No No AB 2018/11/27 SUNNY
212492 001 ANDA AMINOCAPROIC ACID AMINOCAPROIC ACID TABLET;ORAL 500MG Prescription No No AB 2019/11/26 AMNEAL
212938 001 ANDA AMINOCAPROIC ACID AMINOCAPROIC ACID TABLET;ORAL 500MG Prescription No No AB 2020/11/06 MSN
211629 001 ANDA AMINOCAPROIC ACID AMINOCAPROIC ACID TABLET;ORAL 500MG Prescription No No AB 2020/12/14 ANI PHARMS
213928 001 ANDA AMINOCAPROIC ACID AMINOCAPROIC ACID TABLET;ORAL 500MG Prescription No No AB 2021/02/12 CARNEGIE
213944 001 ANDA AMINOCAPROIC ACID AMINOCAPROIC ACID TABLET;ORAL 500MG Prescription No No AB 2022/09/14 OPTIMUS
活性成分:AMINOCAPROIC ACID 剂型/给药途径:TABLET;ORAL 规格:1GM 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
015197 002 NDA AMICAR AMINOCAPROIC ACID TABLET;ORAL 1GM Discontinued Yes No AB 2004/06/24 HIKMA
209060 002 ANDA AMINOCAPROIC ACID AMINOCAPROIC ACID TABLET;ORAL 1GM Prescription No Yes AB 2018/11/27 SUNNY
213928 002 ANDA AMINOCAPROIC ACID AMINOCAPROIC ACID TABLET;ORAL 1GM Prescription No No AB 2021/02/12 CARNEGIE
213944 002 ANDA AMINOCAPROIC ACID AMINOCAPROIC ACID TABLET;ORAL 1GM Prescription No No AB 2022/09/14 OPTIMUS
212938 002 ANDA AMINOCAPROIC ACID AMINOCAPROIC ACID TABLET;ORAL 1GM Prescription No No AB 2023/09/13 MSN
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database